Oncocross Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	370.46	1,072	91.52	150.25	100
Other Revenue	-	-	-	-	-0
Revenue	370.46	1,072	91.52	150.25	100
Revenue Growth (YoY)	-65.45%	1071.49%	-39.08%	50.24%	11.11%
Cost of Revenue	31.22	4.27	88.31	121.74	38.66
Gross Profit	339.24	1,068	3.21	28.51	61.34
Selling, General & Admin	4,849	4,563	3,412	3,636	4,258
Research & Development	3,297	2,956	2,871	5,926	2,824
Amortization of Goodwill & Intangibles	18.82	19.95	20.96	20.33	16.71
Other Operating Expenses	211.48	107.61	96.63	99.84	63.54
Operating Expenses	9,167	8,033	6,813	10,028	7,401
Operating Income	-8,828	-6,965	-6,810	-9,999	-7,339
Interest Expense	-526.27	-18.79	-38.31	-76.49	-5,341
Interest & Investment Income	389.45	324.62	125.38	101.6	67.25
Currency Exchange Gain (Loss)	-0.48	-2.17	-6	-3.35	-1.21
Other Non Operating Income (Expenses)	-111.64	28.6	2,357	-121.84	-600.42
EBT Excluding Unusual Items	-9,077	-6,633	-4,372	-10,099	-13,215
Gain (Loss) on Sale of Investments	178.18	149.39	265.78	-85.56	68.5
Gain (Loss) on Sale of Assets	-29.79	0	-	-19.19	-
Pretax Income	-8,929	-6,483	-4,106	-10,204	-13,146
Income Tax Expense	-	-	108.26	-	-
Net Income	-8,929	-6,483	-4,214	-10,204	-13,146
Net Income to Common	-8,929	-6,483	-4,214	-10,204	-13,146
Shares Outstanding (Basic)	12	10	9	9	5
Shares Outstanding (Diluted)	12	10	9	9	5
Shares Change (YoY)	14.12%	17.54%	1.44%	63.74%	0.83%
EPS (Basic)	-747.00	-619.00	-472.98	-1161.74	-2450.70
EPS (Diluted)	-747.00	-619.00	-473.00	-1161.74	-2451.00
Free Cash Flow	-10,702	-5,687	-4,913	-8,527	-6,534
Free Cash Flow Per Share	-895.35	-542.98	-551.42	-970.80	-1218.13
Gross Margin	91.57%	99.60%	3.51%	18.98%	61.34%
Operating Margin	-2383.02%	-649.58%	-7440.64%	-6655.30%	-7339.31%
Profit Margin	-2410.17%	-604.66%	-4604.70%	-6791.63%	-13146.17%
Free Cash Flow Margin	-2888.81%	-530.40%	-5368.32%	-5675.38%	-6534.38%
EBITDA	-8,018	-6,558	-6,372	-9,630	-7,082
D&A For EBITDA	809.92	406.66	438.4	369.13	257.59
EBIT	-8,828	-6,965	-6,810	-9,999	-7,339
Advertising Expenses	266.46	113.9	31.53	123.36	97.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.